BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ampio Pharmaceuticals, Inc. 

5445 DTC Parkway, P4

Greenwood Village  Colorado  80111  U.S.A.
Phone: 303-418-1000 Fax: 303-418-1001


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Ampio Pharmaceuticals, Inc. (AMPE) Could Have A Blockbuster Fourth Quarter, Says Citi 10/29/2014 1:06:04 PM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Results Of The Open Label Portion Of The Multiple Intra-Articular Injections (MI) Study Of Ampion™ In Patients With Osteoarthritis Of The Knee At Week Twelve Of The Trial 10/17/2014 7:19:35 AM
Wall Street Shouldn't Write Off Ampio Pharmaceuticals, Inc. (AMPE) Yet: Citi Analysts 9/16/2014 2:21:24 AM
Ampio Pharmaceuticals, Inc. (AMPE) Announces Webcast For Annual Shareholder Meeting 9/15/2014 10:09:24 AM
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee 9/2/2014 1:30:35 PM
Letter To The Ampio Pharmaceuticals, Inc. (AMPE) Shareholders In Regard To The STEP Study And Ampio's Plans For The Ampion™ BLA 8/25/2014 10:19:48 AM
Ampio Pharmaceuticals, Inc. (AMPE) Reports That Due To Temperature Deviations Below Product Specifications During Shipments To The Ampion™ STEP Study Clinical Sites, Release Of Data Will Be Delayed 8/21/2014 7:32:26 AM
Ampio Pharmaceuticals, Inc. (AMPE) Release: Analysis Of Available Data From Optimeyes Study (Blinded And Open Label) Of Optina™ For The Treatment Of Diabetic Macular Edema (DME) Indicates Potential For Significant Clinical Benefit 8/20/2014 7:31:30 AM
Ampio Pharmaceuticals, Inc. (AMPE) Touts Very Positive Data For Ampion Osteoarthrtis Study 8/18/2014 6:20:52 AM
Ampio Pharmaceuticals, Inc. (AMPE) Updates On Positive One-Month Results From Ampion Open Label Study 8/5/2014 6:56:25 AM
12345678910...